Skip to main content
SINPHAR logo

SINPHAR — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Filings indexed 1,611 across all filing types
Latest filing 2021-09-14 Declaration of Voting R…
Country TW Taiwan
Listing TW 1734

About SINPHAR

www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
代重要子公司SUNETIC BIOTECH INC.股東常會重要決議事項公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of important resolutions from a subsidiary's Annual General Meeting (股東常會) held on 110/09/14 (Taiwanese calendar year). It lists decisions such as approval of earnings distribution, financial statements, and other meeting matters. The document is short (654 characters) and serves as a formal announcement of voting results from the shareholder meeting. It does not contain the full financial report or detailed financial data itself, but rather the outcomes of the meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-09-14 Chinese
代重要子公司SUNETIC BIOTECH INC.董事會 公告決議股利分派事宜
Notice of Dividend Amount Classification · 95% confidence The document is a short announcement (510 characters) regarding a board resolution on dividend distribution by a subsidiary company. It specifies the dividend amount and the date of the board meeting. There is no detailed financial report or comprehensive data, only a brief notice of dividend decision. According to the rules, such announcements about dividend amounts and payment details fall under the category 'Notice of Dividend Amount (DIV)'. The document is not a full report but a specific dividend announcement.
2021-09-14 Chinese
代重要子公司杏輝天力(杭州)藥業有限公司董事會 公告決議股利分派事宜
Notice of Dividend Amount Classification · 95% confidence The document is a short announcement from a company about a board resolution regarding dividend distribution for a subsidiary. It specifies the dividend amount and the date of the board meeting. The document length is only 504 characters, indicating it is a brief announcement rather than a full report. The content focuses on dividend declaration details, which aligns with the category for Notice of Dividend Amount (DIV).
2021-09-14 Chinese
110年8月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summary report of net operating revenue for a company named 杏輝 for the period 民國110年08月 (August 2021). It contains monthly and cumulative revenue figures with percentage changes compared to the previous year. The document is short (774 characters) and appears to be a financial summary or revenue update rather than a full financial report. There is no indication of detailed financial statements, management discussion, or audit information. It is not an earnings release since it lacks key highlights or narrative commentary. It is also not an announcement of a report publication or a certification. The content fits best with a brief financial summary or factsheet type document. Therefore, the most appropriate classification is Fund Information / Factsheet (FS).
2021-09-10 Chinese
110年8月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (杏輝) providing information about loan balances and endorsement guarantees for the current and previous months. It contains tabular data with monetary amounts but is very short (615 characters) and does not include comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure of specific financial data rather than a full report or announcement of a report. There is no indication of an annual or interim report, audit report, or other detailed filings. Given the nature and length, this fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2021-09-10 Chinese
110年08月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, chairpersons, and senior management, with specific numbers of shares held, changes in holdings, and related notes. The content is focused on insider share transactions and holdings rather than financial results, management commentary, or corporate governance policies. There is no indication of a full financial report, earnings release, or meeting materials. The document is not a report publication announcement or a certification. Given the detailed insider shareholding data, this fits the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades). The document length is substantial and contains substantive data on insider holdings and changes, consistent with DIRS filings.
2021-09-08 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.